Abstract
The activity and levels of the metazoan HIF (hypoxia-inducible factor) are regulated by its hydroxylation, catalysed by 2OG (2-oxoglutarate)- and Fe(II)-dependent dioxygenases. An oxygen consumption assay was developed and used to study the relationship between HIF hydroxylase activity and oxygen concentration for recombinant forms of two human HIF hydroxylases, PHD2 (prolyl hydroxylase domain-containing protein 2) and FIH (factor inhibiting HIF), and compared with two other 2OG-dependent dioxygenases. Although there are caveats on the absolute values, the apparent Km (oxygen) values for PHD2 and FIH were within the range observed for other 2OG oxygenases. Recombinant protein substrates were found to have lower apparent Km (oxygen) values compared with shorter synthetic peptides of HIF. The analyses also suggest that human PHD2 is selective for fragments of the C-terminal over the N-terminal oxygen-dependent degradation domain of HIF-1α. The present results, albeit obtained under non-physiological conditions, imply that the apparent Km (oxygen) values of the HIF hydroxylases enable them to act as oxygen sensors providing their in vivo capacity is appropriately matched to a hydroxylation-sensitive signalling pathway.
Keywords: dioxygenase, glucose oxidase (GOX), hydroxylase, hypoxia-inducible factor (HIF), 2-oxoglutarate (2OG), oxygen consumption assay
Abbreviations: c, calculated; CAD, C-terminal transcriptional activation domain; CODD, C-terminal oxygen-dependent degradation domain; ESI-MS, electrospray ionization MS; FIH, factor inhibiting HIF; GOX, glucose oxidase; HIF, hypoxia-inducible factor; NODD, N-terminal oxygen-dependent degradation domain; o, observed; 2OG, 2-oxoglutarate; PAHX, phytanoyl-CoA hydroxylase; mPAHX, mature PAHX; PHD, prolyl hydroxylase domain-containing protein; SPR, surface plasmon resonance; TauD, taurine dioxygenase
INTRODUCTION
The α/β-heterodimeric protein HIF (hypoxia-inducible factor) is a central regulator in the response of metazoans to hypoxia [1,2]. Human HIF regulates the transcription of genes encoding proteins involved in glycolysis, erythropoiesis and angiogenesis that counteract the effects of hypoxia [3,4]. Manipulating the hypoxic response is of therapeutic interest both from the perspectives of cancer (inhibiting HIF activity) and ischaemic disease (promoting HIF activity). In contrast with the levels of the β-subunit, which is constitutively expressed [5], both the activity and levels of the HIF-α subunits are regulated by oxygen.
In both the HIF-1α and HIF-2α forms of HIF-α, the N-terminal domain contains subdomains that enable dimerization with HIF-1β and binding to response elements linked to hypoxic response genes [6]. The central HIF-1α region contains the structural elements involved in its oxygen-dependent proteolytic degradation. In the presence of sufficient oxygen, HIF-α undergoes trans-4-hydroxylation of two proline residues within LXXLAP motifs (Pro402 and Pro564 in human HIF-1α) [7,8]. This modification enables binding of the HIF-α subunits to the pVHL (von Hippel–Lindau protein), which targets HIF-α for ubiquitination and proteasomal degradation. Human HIF-1α and HIF-2α also possess a conserved site of asparagine hydroxylation (Asn803 of HIF-1α) in their CADs (C-terminal transcriptional activation domains) [9]. Hydroxylation at the pro-S β-position of Asn803 [10] ablates the interaction between HIF and the transcriptional co-activator p300, thus blocking HIF-mediated transcription [11,12].
In humans, HIF-α proline hydroxylation is catalysed by three Fe(II)-dependent dioxygenases PHD1–3 (proline hydroxylase domain-containing enzymes 1–3; or EGLN2/1/3 or HPH3/2/1), with closely related catalytic domains [13,14]. Asparagine hydroxylation of the HIF-α CAD is also catalysed by a dioxygenase, FIH (factor inhibiting HIF) [15,16]. The four identified human HIF hydroxylases belong to the non-haem Fe(II) and 2OG (2-oxoglutarate) dioxygenase superfamily [3,17,18]. Like most other family members they catalyse the incorporation of one oxygen atom from dioxygen into their alcohol product and one into the succinate co-product [15,19,20].
Using baculovirus-produced PHDs, Hirsilä et al. [21] reported Km (oxygen) values for the PHDs (230–250 μM) that were higher than that of human procollagen proline 4-hydroxylase (40 μM), an observation interpreted as being significant in terms of the role of the PHDs as oxygen sensors. Koivunen et al. [22] reported a lower Km (oxygen) value for FIH (90 μM) and argued that a larger decrease in oxygen concentration was required for a significant decrease in FIH activity compared with the PHDs. These studies on the PHDs and FIH were conducted using crude baculovirus extracts and peptide fragments of HIF-α. However, there is evidence that short fragments of HIF-α may not be representative substrates for the intact protein, e.g. a 35-residue fragment of the HIF-α CAD is reported to be a better substrate for FIH than a 19-residue fragment, and the minimum effective substrate reported for PHD2 is approx. 17 residues long [21–23].
To address the question of whether, particularly in terms of their oxygen-binding characteristics, the HIF hydroxylases have unusual features within the 2OG dioxygenase superfamily, we developed an assay that continuously measures oxygen consumption to investigate the oxygen and co-substrate dependence of FIH and PHD2 using a range of substrates. Comparison of the data with other 2OG-dependent dioxygenases (Figure 1) indicates that the Km (app; oxygen) values of the HIF hydroxylases are likely within the typical range for the 2OG dioxygenases. Together with biophysical data, the results imply that PHD2 is selective in binding CODD (C-terminal oxygen-dependent degradation domain) over the NODD (N-terminal oxygen-dependent degradation domain) fragment of HIF-1α, and that catalytic efficiency is dependent on the substrate length. The present study has implications both for modelling the role of the HIF hydroxylases in the hypoxic response and for the design of in vitro assays to identify HIF hydroxylase inhibitors aimed at inducing the hypoxic response.
Figure 1. Reactions catalysed by the non-haem Fe(II)- and 2-OG-dependent dioxygenases used in the present study.
(A) PHDs, (B) FIH, (C) TauD and (D) mPAHX.
EXPERIMENTAL
Materials
Chemicals were obtained from Sigma–Aldrich, oxygen/nitrogen gas mixtures were from BOC Gases, and synthetic peptides were from Peptide Protein Research Ltd, Fareham, Hants. U.K.
Expression and purification of recombinant 2OG-dependent dioxygenases and substrates
FIH and PHD2181–426 were produced essentially as reported in [15,24]. In brief, the full-length fih gene and an N-terminally truncated phd2 gene encoding PHD2181–426 were subcloned into the pET-28a(+) vector (Novagen) as NdeI/BamHI or NheI/BamHI fragments. Proteins were expressed in Escherichia coli BL21(DE3) in 2YT [1.6% (w/v) tryptone, 1% (w/v) yeast extract and 0.5% (w/v) NaCl] growth medium. Cells were induced with 0.5 mM isopropyl β-D-thiogalactoside when D600=0.8–1.0 and growth was continued at 37 °C for 4 h before cell harvest. Purification of the N-terminally His6-tagged (N-MGSSHHHHHHSSGLVPRGSH) proteins were carried out using nickel-affinity chromatography on HisBind-IDA resin (Novagen) according to the manufacturer's instructions. Cleavage of the affinity tag was achieved by incubation of the fusion protein for 16 h at 4 °C with thrombin (Novagen). Desalting on a 300 ml Superdex-75 column (GE Healthcare) yielded approx. 95% pure protein as judged by SDS/PAGE analysis. Proteins were characterized by ESI–MS (electrospray ionization MS): FIH c (calculated) 40566, o (observed) 40569 Da; PHD2181–426 c28056, o28056 Da; and His6–PHD2181–426 c29807, o29805 Da. For SPR (surface plasmon resonance) analyses, the sequence encoding PHD2181–426 was subcloned into the pET-24a(+) vector (Novagen) to produce protein lacking an N-terminal His6 tag, expressed as described above, then purified by cation-exchange and size-exclusion chromatography to >95% purity as judged by SDS/PAGE analysis (ESI-MS data: c27643 and o27646 Da). The N-terminally truncated form of PHD2 was chosen as it can be easily produced in E. coli.
His6–HIF-1α344–503 NODD and His6–HIF-1α530–698 CODD were prepared as described in [14,15] (ESI-MS data: His6–HIF-1α344–503 NODD c19762, o19763 Da; His6–HIF-1α530–698 CODD c20808, o20808 Da). His6–HIF-1α530–652 CODD, His6–HIF-1α653–826 CAD and His6–HIF-2α502–697 CODD were expressed from pET-28a(+) constructs in E. coli BL21(DE3) and purified using nickel-affinity chromatography as reported for the other HIF fragments [14,15]. Short HIF fragments (35 residues or less: HIF-1α556–574 CODD, HIF-1α788–806 CAD, HIF-1α788–822 CAD and HIF-2α832–866 CAD) were prepared by synthesis.
The mature form (i.e. lacking the N-terminal peroxisomal targeting sequence) of mPAHX (mature phytanoyl-CoA hydroxylase) [25] and TauD (taurine dioxygenase) [26] were produced as reported (ESI–MS data: mPAHX, c35435, o35436 Da; and TauD c32278, o32282 Da).
Oxygen consumption assay
Assays were carried out under conditions of reduced light. GOX (glucose oxidase) assays were carried out in a final volume of 200 μl at 25 °C. The final reaction mixture consisted of 32 pM GOX (Sigma–Aldrich), 10 nM catalase and 5–200 mM glucose in 50 mM sodium acetate (pH 5.5). Rubber-septum-sealed reaction vials containing glucose at various concentrations in sodium acetate buffer were exchanged with the appropriate gas mixture to give the required final oxygen concentration, and catalase was then added. The reaction vial was placed in a stirred water bath and a FOXY AL-300 probe (Ocean Optics Ltd.) inserted through the septum into the vial. The mixture was equilibrated and the reaction then initiated by the injection of GOX using a Hamilton syringe (50 μl). Oxygen levels were monitored in the absence of ambient light using a fibre-optic oxygen-sensor system (FOXY, OceanOptics), calibrated using oxygen-saturated water [27], and an oxygen-depleted aqueous solution (prepared by adding crystalline Na2SO3). Only the rate of consumption within the first 5–20% of conversion (linear) was considered. Kinetic data were analysed with SigmaPlot 2000.
Assays with the 2OG-dependent dioxygenases were carried out essentially as described above at 37 °C, in 50 mM Tris/HCl (pH 7.5) unless otherwise stated. FIH (40 μM) was reconstituted with 40 μM FeSO4 and injected into a solution of 1.5 mM 2OG (unless otherwise stated). The reaction was initiated by substrate addition. Assays of His6–PHD2181–426 followed the same procedure using 50 μM PHD2181–426 reconstituted with 50 μM FeSO4 injected into a solution of 0.75 mM 2OG (unless otherwise stated). Assays using TauD were carried out in 10 mM imidazole buffer (pH 6.9) using 10 μM TauD, 100 μM Fe(II), 0.5 mM 2OG and 0.5 mM taurine as a standard. Assays using mPAHX were carried out using 50 μM mPAHX, 50 μM Fe(II), 1.25 mM 2OG and 0.25 mM isovaleryl-CoA.
Km (app; sub) and Km (app; 2OG) values were determined at ambient oxygen concentrations (220 μM) by varying the concentration of either the substrate or the co-substrate. For Km (app; oxygen) value determination, different oxygen concentrations were obtained by exchanging the 2OG and Tris/HCl buffer solution with oxygen/nitrogen gas mixtures. The Michaelis–Menten equation was fitted directly to the data using SigmaPlot 2000, and values are quoted as a mean of at least three independent measurements. Vmax values were derived from Michaelis–Menten curves for substrate dependence, and kcat and kcat/Km (app) determined using these data.
SPR
Binding studies were carried out on a BIAcore 2000™ biosensor (Biacore AB). His6–HIF-1α344–503 NODD or His6–HIF-1α530–698 CODD protein substrates were covalently coupled with a CM5 sensor chip using the BIAcore Amine Coupling kit (BIAcore AB) at pH 4.5. After controls were performed to eliminate mass-transport effects, ligands were bound such that response units increased by approx. 800. Analyte protein (15 μl) was injected over the experimental and control flow cells at 50 μl/min and 25 °C in 10 mM Hepes (pH 7.4), 150 mM NaCl and 0.005% surfactant P20. PHD2181–426 [pET-24a(+)] binding experiments were performed over a range of concentrations and kinetic data were calculated using the BIAevaluation software (BIAcore AB).
RESULTS
Development of an oxygen consumption assay
None of the reported HIF hydroxylase assays in vitro have measured oxygen consumption; instead they analyse 2OG/succinate production or HIF-α hydroxylation. To investigate their oxygen dependency it was desirable to develop an assay that directly measured oxygen consumption. Following initial work with Clark electrodes, we selected a fibre-optic oxygen-sensing system (FOXY, Ocean Optics Ltd.) for further evaluation as it is suited for assays in small volumes (<200 μl), can continuously monitor oxygen levels and allows the use of sealed vials, so enabling assays under different oxygen concentrations [28]. As it displays well-defined Michaelis–Menten kinetics, GOX was used to validate the technique [29]. The results [Km (glucose) 23±2 mM; Km (app; oxygen) 140±10 μM, Figure 2] were in agreement with previous results obtained with a Clark electrode [Km (glucose)=26 mM; Km (app; oxygen)=200 μM] [30]. Under reduced light conditions reproducible data across a range of dissolved oxygen levels in small sample volumes (200 μl) were obtained. Thus, although the interference by ambient light is a limitation, the fibre-optic sensor is a viable alternative to Clarke electrode assays.
Figure 2. Kinetic studies of the GOX using the oxygen consumption assay at 25 °C in 50 mM NaOAc sodium acetate (pH 5.5).
GOX activity with different concentrations of (A) glucose and (B) oxygen.
Oxygen consumption assay conditions for HIF hydroxylases
Using the conditions described above, when applied to the HIF hydroxylases, sufficient rates of oxygen consumption for reliable assays were only achieved using micromolar concentrations of enzymes and a relatively high enzyme/substrate ratio (∼1:5). The addition of potential stabilizing and/or reducing compounds including DTT (dithiothreitol), BSA and catalase did not make a significant difference to the initial rate measurements and were omitted (results not shown). Ascorbate is reported to be necessary for optimal stimulation of activity of several 2OG-dependent oxygenases, including procollagen proline hydroxylase [31] and PHD (and to a lesser extent FIH) [21,22], and stimulation of PHD activity in cells [32]. The addition of ascorbate to a PHD2181–426 assay containing Fe(II) resulted in significant oxygen consumption in the absence of enzyme (results not shown); ascorbate is a reducing agent and can reduce molecular oxygen to water, a reaction stimulated by transition-metal ions, including Fe(III) [33]. Ascorbate was therefore excluded from the oxygen-consumption assay mixtures with a consequent possible decrease in catalytic efficiency.
Kinetic parameters for PHD2181–426 and HIF-1α CODD and NODD substrates
The oxygen-sensor method was then used to assay PHD2181–426 with HIF1-α and HIF2-α fragments of different length. The apparent Km values for 2OG and oxygen obtained with the HIF-1α556–574 CODD peptide (Table 1) were consistent with those of previous experiments employing the [14C]2OG capture assay on PHD21–426 isolated from crude insect cell extracts (Table 1) [21]. The specific activity of 1.6 mol of oxygen per min per mol of PHD2181–426 when assayed with HIF-1α556–574 CODD (Table 1) was the same as that reported previously for highly purified PHD2181–426 [34] but was approx. 20-fold lower than specific activities of full-length PHD21–426 in crude cell extracts in the presence of ascorbate (>40–55 mol of oxygen/min per mol of full-length PHD21–426) (Table 1) [21].
Table 1. Kinetic parameters for PHD2181–426 for the synthetic peptide HIF-1α556–574 CODD (19 residues) and recombinant substrates (>120 residues; sub) from the HIF-α ODDD.
The oxygen consumption assays were performed in 50 mM Tris/HCl (pH 7.5) at 37 °C (entries 1+3+4+5), except for His6–HIF-2α502–697 CODD, which was assayed in 250 mM Tris/HCl (pH 8.0) (entry 6). Entry 2 refers to data reported in [21], obtained under different conditions. aa, amino acid.
| Entry | Enzyme | Substrate | Length (aa) | Vmax (μM/s) | Km (app; sub) (μM) | Km (app; 2OG) (μM) | Km (app, oxygen) (μM) | kcat (min−1) | kcat/Km (app) (M−1·s−1) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PHD2181–426 | HIF-1α556–574 CODD | 19 | 1.30±0.30 | 21.6±7 | 55±11 | 229±60 | 1.6 | 1,204 |
| 2 | PHD21–426 | HIF-1α556–574 CODD | 19 | ND | 7 | 60 | 250 | >40–55 | >(95–131)×103 |
| 3 | His6–PHD2181–426 | His6–HIF-1α530–652 CODD | 123 | 0.180±0.004 | 2.3±0.3 | ND | 76±11 | 0.54 | 3863 |
| 4 | His6–PHD2181–426 | His6–HIF-1α530–698 CODD | 169 | 0.074±00.003 | 1.8±0.5 | 75±20* | 81±28 | 0.22 | 1968 |
| 5 | His6–PHD2181–426 | His6–HIF-1α344–503 NODD | 160 | 0.97±0.07 | 24±7 | 58±20 | 85±17 | 1.16 | 805 |
| 6 | His6–PHD2181–426 | His6–HIF-2α502–697 CODD | 195 | 0.3±0.001 | 15±2 | 267±34 | 67±10 | 0.42 | 467 |
In comparison with the 19-residue HIF-1α556–574 CODD fragment (Table 1), when longer HIF-1α CODD fragments were used (His6–HIF-1α530–652 CODD and His6–HIF-1α530–698 CODD) lower Km (app; sub) (substrate) values of 2.3 and 1.8 μM respectively were observed (Table 1; Figure 3), demonstrating that the kinetic parameters can be affected by length of substrate. The low Km (app; sub) value for His6–HIF-1α530–698 CODD obtained with this assay was confirmed by the [14C]2OG capture assay (results not shown).
Figure 3. Kinetic studies of the HIF hydroxylases using the oxygen consumption assay at 37 °C in 50 mM Tris/HCl (pH 7.5).
His6–PHD2181–426 activity was assayed with different concentrations of (A) His6–HIF-1α530–652 CODD and (B) HIF-1α556–574 CODD.
The Km (app; sub) value for the CODD fragment (1.8 μM) was significantly lower than for the NODD fragment [Km (app; sub)=24 μM], suggesting that the difference in specific activity for the two fragments was due to differential binding. To investigate this possibility, SPR analyses were carried out. Although conducted under conditions different from the oxygen sensing assay [notably in the absence of added Fe(II)], the SPR data indicated that PHD2181–426 preferentially binds His6–HIF-1α530–698 CODD over His6–HIF-1α344–503 NODD. The association rate constants for the two fragments were very similar (1.56±0.49 and 1.37±0.42 M−1·s−1 respectively), but the observed dissociation rate constant for His6–HIF-1α530–698 CODD was lower than that of His6–HIF-1α344–503 NODD (0.186±0.04 s−1 compared with 0.697±0.24 s−1, n=6, P<0.001 respectively) (Figure 4). These data indicate that the differences in Km (app; sub) values are due, at least in part, to differences in binding. The variation between the rate constants for PHD2 dissociating from CODD and NODD were more pronounced in the presence of equimolar (with respect to enzyme) 2OG, at 0.121±0.02 and 0.68±0.28 s−1 (n=6) respectively (results not shown).
Figure 4. SPR data for PHD2181–426 binding to His6–HIF-1α530–698 CODD and His6–HIF-1α344–503 NODD.
(A) PHD2 (250 nM, 500 nM, 750 nM and 1 μM) binding to His6–HIF-1α530–698 CODD: dissociation rate constant 0.186±0.04 s−1. (B) PHD2 (1, 1.5, 2 and 2.5 μM) binding to His6–HIF-1α344–503 NODD: dissociation rate constant 0.697±0.24 s−1.
The Km (app) values for 2OG and oxygen were then determined using the different length substrates. For the HIF-1α substrates tested the Km (app; 2OG) values for His6–PHD2181–426 were in the range of 55–75 μM (Table 1) and apparently unaffected by either the length or type (NODD or CODD) of substrate. A caveat on the 2OG data is that the possibility of some 2OG co-purification with PHD2181–426 cannot be excluded [34]; data from other assays imply the binding constant for 2OG is much lower than the Km (app) values reported here (∼1 μM). The apparent Km (app; oxygen) for His6–PHD2181–426 was approx. 81 μM for His6–HIF-1α530–698 CODD (Figure 5A), which was about the same as for His6–HIF-1α344–503 NODD (85 μM) and lower than that for the 19-residue peptide HIF-1α556–574 CODD of 229 μM, implying that, under these assay conditions, the length of the substrate influences the apparent Km (app; oxygen) (Table 1). Oxygen concentrations above 220 μM (ambient oxygen levels) caused substrate inhibition (results not shown), possibly due to oxidation of iron at the enzyme active site, although inactivating or inhibiting oxidation at other sites including exposed cysteine residues [35] on the surface of PHD2 is also possible. Notably for His6–PHD2181–426 there was little oxygen consumption prior to the addition of substrate (in contrast with FIH) consistent with the possibly important ability of this enzyme to form a relatively stable enzyme·Fe(II)·2OG intermediate.
Figure 5. Kinetic studies of the HIF hydroxylases using the oxygen depletion assay at 37 °C in 50 mM Tris/HCl (pH 7.5).
The oxygen dependencies of (A) His6–PHD2181–426 with His6–HIF-1α530–698 CODD and (B) His6–FIH with His6–HIF-1α653–826 CAD.
Kinetic parameters for PHD2181–426 and HIF-2α substrates
It has not yet been possible to produce a sufficiently soluble (without additives for the current assay conditions) recombinant substrate fragment of His6–HIF-2α350–476 NODD. A soluble His6–HIF-2α502–697 CODD fragment was obtained, but it was found necessary to carry out assays at pH 8.0 and at high buffer concentrations (250 mM Tris/HCl) to maintain substrate solubility. Both the Km (app; sub) and Km (app; 2OG) values for His6–HIF-2α502–697 CODD were significantly higher compared with the equivalent parameters for the His6–HIF-1α530–698 CODD, but the different assay conditions make direct comparisons of limited value (Table 1, entries 4+6). In contrast, the Km (app; oxygen) value for the recombinant His6–HIF-2α502–697 CODD fragment of 67 μM (Table 1) is below the value of the HIF-1α equivalents of 81 μM (His6–HIF-1α530–698 CODD) and 85 μM (His6–HIF-1α344–503 NODD). However, given the variations in conditions between the two assays, this difference should probably not be regarded as being significant.
Kinetic parameters for FIH
Km (app; sub) values (Table 2) for each of the HIF-1α CAD fragment substrates (19 and 35 residues, HIF-1α788–806 CAD and HIF-1α788–822 CAD) were at 395 and 222 μM respectively, in reasonable agreement with the reported values, obtained with different techniques (Table 2) [22,24]. As with PHD2181–426 there was a decrease in the apparent Km (app; sub) value (to 154 μM) when using a longer substrate, His6–HIF-1α653–826 CAD (Table 2), but the effect was less pronounced than for PHD2 (Table 1). The Km (app; 2OG) value of FIH (64 μM) observed with His6–HIF-1α653–826 CAD (Table 2) was a similar value to that obtained for PHD2181–426 with a similar length substrate (Table 1). The Km (app; oxygen) for FIH was 237 μM with His6–HIF-1α-653–826 CAD (Figure 5B) and 145 and 150 μM with the 19- and 35-residue peptides (HIF-1α788–806 CAD and HIF-1α788–822 CAD) respectively (Table 2), i.e. above the Km (app; oxygen) values of PHD2181–426 assayed with His6–HIF-1α530–698 CODD (110 μM) and His6–HIF-1α344–503 NODD (85 μM) (Table 1). FIH assayed with a HIF-2α832–866 CAD 35-residue peptide revealed Km (app; sub) (229 μM), Km (app; 2OG) (119 μM), Km (app; oxygen) (110 μM) values that were similar to the Km values for the HIF-1α equivalent HIF-1α788–822 CAD peptide. (Table 2).
Table 2. Kinetic parameters for FIH wild-type, for the synthetic peptides HIF-1α788–806 CAD and HIF-1α788–822 CAD (19 and 35 residues) and a recombinant substrate (>120 residues) representing the HIF-α CAD region.
Assays were performed using the oxygen consumption assay in 50 mM Tris/HCl (pH 7.5) at 37 °C (entries 1+3+6) except His6–HIF-1α653–826 CAD, which was assayed in 50 mM CHES [2-(N-cyclohexylamino)ethanesulfonic acid] (pH 9.9) (entry 6). Entries 2, 4 and 5 refer to reported data obtained under different conditions. aa, amino acid.
| Entry | Enzyme | Substrate | Length (aa) | Vmax (μM/s) | Km(app; sub) (μM) | Km(app; 2OG) (μM) | Km(app; oxygen) (μM) | kcat (min−1) | kcat/Km(app) (M−1·s−1) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | FIH | HIF-1α788–806 CAD | 19 | 21±3 | 395±180 | 143±49 | 145±33 | 31.5 | 1329 |
| 2* | FIH | HIF-1α788–806 CAD | 19 | ND | 420±50 | ND | ND | ND | ND |
| 3 | FIH | HIF-1α788–822 CAD | 35 | 9.7±0.5 | 222±30 | 147±46 | 150±30 | 14.55 | 1092 |
| 4* | FIH | HIF-1α788–822 CAD | 35 | ND | 205±30 | 114±25 | ND | ND | ND |
| 5† | FIH | HIF-1α788–822 CAD | 35 | ND | 100±5 | 25±3 | 90±20 | 70–135 | (11–23)×103 |
| 6 | FIH | His6–HIF-1α653–826 CAD | 173 | 0.32±0.04 | 154±37 | 64±25 | 237±28 | 1.92 | 208 |
| 7 | FIH | HIF-2α832–866 CAD | 35 | 1.12±0.1 | 229±70 | 119±47 | 110±73 | 6.7 | 489 |
Results for mPAHX and TauD
We assayed two other 2OG-dependent oxygenases; E. coli TauD and human PAHX, for comparison with the HIF hydroxylases. The Km values for the substrates and 2OG of these enzymes have been studied previously, but not their direct dependence on oxygen [36,37]. Owing to the scarcity of the natural phytanoyl-CoA substrate and complications with kinetic studies due to its lack of solubility in aqueous solvents [36], isovaleryl-CoA was used as a substrate for the PAHX work as it does not require solubilization agents [25]. The isovaleryl-CoA substrate displayed Michaelis–Menten behaviour using the oxygen sensor assay, but has a higher apparent Km (app) than phytanoyl-CoA (Table 3). The apparent Km (app; 2OG) value was also higher for isovaleryl-CoA than phytanoyl-CoA and was high in comparison with reported values for other 2OG oxygenases (50–90 μM). The results for TauD [Km (app; sub)=54 μM and Km (app; 2OG)=90 μM] were also within the same order of magnitude of previously reported data measured with a different assay [Km (app; sub)=55 μM and Km (app; 2OG)=11 μM; Table 3] [37]. Under the assay conditions, the apparent Km (app; oxygen) values for PAHX (with isovaleryl-CoA as a substrate) and TauD were 93 and 76 μM respectively (Table 3).
Table 3. Kinetic parameters for other Fe(II)- and 2OG-dependent oxygenases.
Assays were performed using the oxygen consumption assay in 50 mM Tris/HCl (pH 7.5) at 37 °C (mPAHX), or 10 mM imidazole (pH 6.9) at 30 °C (TauD). ND, not determined.
| Entry | Enzyme | Substrate | Vmax (μM/s) | Km(sub) (μM) | Km(2OG) (μM) | Km(oxygen) (μM) | kcat (min−1) | kcat/Km (M−1·s−1) |
|---|---|---|---|---|---|---|---|---|
| 1 | mPAHX | Isovaleryl-CoA | 0.77±0.10 | 356±118 | 186±46 | 93±43 | 0.98 | 46 |
| 2* | mPAHX | Phytanoyl-CoA | ND | ∼30 | 50±15 | ND | ND | ND |
| 3 | TauD | Taurine | 4.8±0.3 | 54±13 | 90±20 | 76±17 | 28.8 | 8888.9 |
| 4† | TauD | Taurine | ND | 55 | 11 | ND | ND | ND |
DISCUSSION
There are important limitations imposed by the use of non-physiological conditions and the constraints imposed by the assays on the absolute kinetic values reported in the present and, likely, previous studies [21,22] on the oxygen-dependency of isolated HIF hydroxylases. These include use of unnatural truncated forms of HIF-α with a single hydroxylation site, use of a truncated form of PHD2 and likely non-optimal assay conditions including, in the present study, the lack of ascorbate (required for optimal in vitro activity) in truncated PHD2181–426 assays, the use of high enzyme-to-substrate ratios and the fact that other proteins may contribute to the interactions being examined, e.g. OS-9 [38]. Most of the activity values reported here are lower than those for the enzymes in crude baculovirus extracts, possibly due to the presence of unassigned stimulatory factors in the extracts. The co-purification of 2OG with recombinant PHD2181–426 [34] also indicates that the 2OG binding constant is significantly lower than the reported Km (app; 2OG) values presented here and elsewhere [21,22]; thus the absolute values should be treated with caution, especially with respect to estimation of binding constants. However, since the aims of the present study, in addition to the development of an oxygen consumption assay for the hydroxylases, were to investigate whether their catalytic efficiency varies with substrate length and whether they have unusual properties within the family of 2OG oxygenases, comparisons between substrates and enzymes are of some value.
An important observation that arises from the results on the oxygen-dependency of the HIF hydroxylases is the variation in catalytic efficiency with different length substrates. Koivunen et al. [22] reported that the activity of FIH with the 19-residue HIF-1α788–806 CAD fragment was approx. 10% of that with a 35-residue HIF-1α788–822 CAD fragment. Consistent with this report we observed a decrease in apparent Km (app; sub) as the length of the HIF-1α substrate fragment was increased from 19 to 35 and to 173 residues (HIF-1α788–806 CAD, HIF-1α788–822 CAD and His6–HIF-1α653–826 CAD) with the Km (app; sub) for the 173-residue fragment being less than half of the 19-residue fragment (Table 2). However, the kcat value of the longest fragment tested, His6–HIF-1α653–826 CAD, was also reduced, meaning there was actually a decrease in kcat/Km (app). The reasons for the apparent decrease in kcat for His6–HIF-1α653–826 CAD are unclear and may reflect non-optimal assay conditions and/or product inhibition.
The variation in catalytic activity of PHD2181–426 with respect to substrate length was more striking than for FIH. Whereas for PHD2181–426 the Km (app; 2OG) values were reasonably consistent for the HIF-1α CODD fragments (55–75 μM), there was a significant reduction in the Km (app; sub) on going from the HIF-1α 19-residue to the 169-residue fragment, and a similar effect for the 123-residue fragment (Table 1). This decrease in Km (app; sub) resulted in a level of activity for His6–HIF-1α530–698 CODD similar to that observed for a 19-residue substrate when using crude baculovirus extracts or human cell extracts [21,39]. Further, the kcat values reported here are likely underestimates, as the catalytic assay conditions used for the oxygen sensor are non-optimal, i.e. ascorbate was absent and a high enzyme to substrate ratio was used. These results indicate that there are important enzyme–substrate recognition processes outside of the 19-residue HIF-1α556–574 CODD sequence that has been previously used as a substrate. It may be that mechanistic studies or efforts to identify inhibitors or activators of the PHDs should utilize substrates reflecting significant fragments of HIF-α or complexes of HIF-α with partner proteins.
There appears to be agreement that all the reported Km (app; sub) values for CAD fragments for FIH are high both in absolute terms and in comparison with the values for PHD2 [21,22]. The cellular significance, if any, of this observation is unclear; however, the Km (app; sub) values for both FIH and the PHDs are significantly higher than the probable concentration range of HIF-α in cells (picomolar to nanomolar); thus it is likely that the effective cellular binding constants for the HIF hydroxylases are significantly lower than the Km (app; sub) values observed with isolated enzymes.
There is evidence that PHD3 is selective for the CODD over the NODD of HIF-1α [14,21]. Both the kinetic and SPR results for PHD2181–426 imply a preferential binding of the His6–HIF-1α530–698 CODD over the His6–HIF-1α344–503 NODD fragment (Table 1; Figure 4). This observation is consistent with the cellular work of Chan et al. [40] that demonstrates that under normoxic conditions the CODD is more efficiently hydroxylated by the PHDs than the NODD in full-length HIF-1α. Since the catalytic domains of all three PHDs are highly conserved, it thus seems possible that they are all selective for the CODD over the NODD sequences, but vary in the degree of selectivity. However, Chan et al. [40] have also provided evidence that the hydroxylation at the two sites is linked (at least modification at the CODD sites affects hydroxylation at the NODD) and it may be that it will be difficult or impossible to obtain full molecular understanding of the relative importance of the roles of the two hydroxylation sites from experiments with isolated CODD and NODD fragments.
For FIH it is noteworthy that with the exception of a reduction in kcat very similar kinetic parameters, Km (app; sub), Km (app; 2OG) and Km (app; oxygen), were obtained for the HIF-1α and HIF-2α 35-residue fragments (HIF-1α788–822 CAD and HIF-2α832–866 CAD) (Table 2). In contrast, the HIF-2α 195-residue fragment His6–HIF-2α502–697 CODD was a significantly poorer substrate for PHD2181–426 than the HIF-1α CODD fragment; however, these data were acquired under different conditions, owing to solubility problems. Hence, accurate comparisons cannot be made and, in contrast with the NODD/CODD selectivity, it is premature to state that PHD2181–426 has a preference for the His6–HIF-1α530–698 CODD over the His6–HIF-2α502–697 CODD (Table 1).
Using data from crude baculovirus-produced PHDs, Hirsilä et al. [21] concluded that the Km (app; oxygen) values for the PHDs (230–250 μM) are significantly higher than for the human 2OG-dependent oxygenase procollagen prolyl-4-hydroxylase (40 μM), a difference in terms of the oxygen-sensing role of the PHDs that was interpreted as being significant. It was argued that the reported Km (app; oxygen) values were slightly above the concentration of dissolved oxygen (atmospheric) and thereby enabled the functions of the PHDs as effective oxygen sensors since “even small decreases in oxygen are likely to influence their [PHD] activities” [21]. Koivunen et al. [22] reported a lower Km (app; oxygen) value for FIH (90 μM) and argued that a larger decrease in oxygen concentration was required for a significant decrease in FIH activity, but noted that the conclusions arising from cell culture experiments may not be valid in tissues.
The present results indicate that the Km (app; oxygen) values for PHD2181–426 and FIH are in the range of 65–240 μM when using a variety of substrates (Tables 1 and 2). For comparison, we carried out the same analyses on two other family members, bacterial TauD and human mPAHX. Although differences were apparent, overall the data, including those obtained using different substrates for PHD2 and FIH, suggest that the HIF hydroxylases are likely to be reasonably typical members of the 2OG oxygenase family, at least with respect to the relationship between catalytic activity and oxygen concentration; the apparent Km (app; oxygen) values for TauD and PAHX were 76 and 93 μM (Table 3) respectively, in the same range as those obtained for PHD2181–426 85–110 μM and FIH 90–240 μM (Tables 1 and 2). In the case of PHD2181–426 it was observed that oxygen levels above 220 μM had an inhibitory effect on efficiency, suggesting that PHD2 is limited towards oxygen concentrations that are higher than ambient levels.
Assuming that the values for Km (app; oxygen) for PHD2181–426 and FIH reflect their oxygen-dependency, the question arises as to whether they are suited to their proposed role as oxygen sensors. It has been argued that, in order for them to act as oxygen-sensing components of the HIF system, the capacity for HIF hydroxylation must be rate-limited by oxygen availability [41]. For this to be the case, the threshold physiological pO2 for a hypoxic response must be below saturating levels for enzymatic activity. Further, the enzymes must not bind oxygen so tightly that they cannot respond appropriately. Reports of oxygen concentrations within cells are in the 30–60 μM range, but may be overestimates as measurements made close to respiring tissue-culture monolayers have indicated surprisingly low values [42]. The available data (albeit imperfect) thus imply the Km (app; oxygen) values for FIH and PHD2181–426 values might be above most physiological concentrations of oxygen they will encounter, indicating that, even under conditions where other factors are not limiting, the oxygen utilization properties of the enzymes are suited to their proposed role as oxygen sensors. If intracellular oxygen concentrations in intact organisms are sufficiently low and the Km (app; oxygen) values of the HIF hydroxylases are sufficiently high for the hydroxylation rate to be oxygen-dependent in any physiological condition, it is still possible that rate is limiting for the overall HIF signalling system over a limited range of oxygen concentrations compared with the full range of oxygen-dependency for the enzymes [41]. Inputs affecting the total hydroxylation capacity of the HIF pathway could effectively match the system to a hypoxic window appropriate for the physiology of a particular cell type or tissue. Such inputs could include relative enzyme/co-substrate/iron concentrations and the presence of reactive oxidizing species present in different redox conditions [43,44]. Indeed it may be that any 2OG oxygenase with a reasonably typical oxygen-sensitivity, or other enzyme similarly endowed, could act as an oxygen sensor if suitably positioned within a signalling pathway.
Acknowledgments
We thank Professor C.W. Pugh from the Wellcome Trust Centre for Human Genetics for the expression constructs and Professor J. Urban from the Department of Physiology, University of Oxford, for discussions. This work was supported by grants from the Wellcome Trust and the Biotechnology and Biological Sciences Research Council. E.F. was supported by funding from ReOx Ltd. D.E. is the recipient of a Fellowship of the Roche Research Foundation and the Freiwillige Akademische Gesellschaft.
References
- 1.Semenza G. L., Wang G. L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 1992;12:5447–5454. doi: 10.1128/mcb.12.12.5447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wang G. L., Jiang B. H., Rue E. A., Semenza G. L. Hypoxia-inducible factor-1 is a basic-helix–loop–helix-Pas heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U.S.A. 1995;92:5510–5514. doi: 10.1073/pnas.92.12.5510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Schofield C. J., Ratcliffe P. J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 2004;5:343–354. doi: 10.1038/nrm1366. [DOI] [PubMed] [Google Scholar]
- 4.Semenza G. L. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology. 2004;19:176–182. doi: 10.1152/physiol.00001.2004. [DOI] [PubMed] [Google Scholar]
- 5.Wang G. L., Semenza G. L. Purification and characterization of hypoxia- inducible factor 1. J. Biol. Chem. 1995;270:1230–1237. doi: 10.1074/jbc.270.3.1230. [DOI] [PubMed] [Google Scholar]
- 6.Jiang B. H., Rue E., Wang G. L., Roe R., Semenza G. L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 1996;271:17771–17778. doi: 10.1074/jbc.271.30.17771. [DOI] [PubMed] [Google Scholar]
- 7.Ivan M., Kondo K., Yang H. F., Kim W., Valiando J., Ohh M., Salic A., Asara J. M., Lane W. S., Kaelin W. G. HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292:464–468. doi: 10.1126/science.1059817. [DOI] [PubMed] [Google Scholar]
- 8.Jaakkola P., Mole D. R., Tian Y. M., Wilson M. I., Gielbert J., Gaskell S. J., von Kriegsheim A., Hebestreit H. F., Mukherji M., Schofield C. J., et al. Targeting of HIF-alpha to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468–472. doi: 10.1126/science.1059796. [DOI] [PubMed] [Google Scholar]
- 9.Lando D., Peet D. J., Whelan D. A., Gorman J. J., Whitelaw M. L. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science. 2002;295:858–861. doi: 10.1126/science.1068592. [DOI] [PubMed] [Google Scholar]
- 10.McNeill L. A., Hewitson K. S., Claridge T. D., Seibel J. F., Horsfall L. E., Schofield C. J. Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the β-carbon of asparagine-803. Biochem. J. 2002;367:571–575. doi: 10.1042/BJ20021162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Dames S. A., Martinez-Yamout M., De Guzman R. N., Dyson H. J., Wright P. E. Structural basis for Hif-1 alpha/CBP recognition in the cellular hypoxic response. Proc. Natl. Acad. Sci. U.S.A. 2002;99:5271–5276. doi: 10.1073/pnas.082121399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Freedman S. J., Sun Z. Y., Poy F., Kung A. L., Livingston D. M., Wagner G., Eck M. J. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc. Natl. Acad. Sci. U.S.A. 2002;99:5367–5372. doi: 10.1073/pnas.082117899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bruick R. K., McKnight S. L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001;294:1337–1340. doi: 10.1126/science.1066373. [DOI] [PubMed] [Google Scholar]
- 14.Epstein A. C., Gleadle J. M., McNeill L. A., Hewitson K. S., O'Rourke J., Mole D. R., Mukherji M., Metzen E., Wilson M. I., Dhanda A., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43–54. doi: 10.1016/s0092-8674(01)00507-4. [DOI] [PubMed] [Google Scholar]
- 15.Hewitson K. S., McNeill L. A., Riordan M. V., Tian Y. M., Bullock A. N., Welford R. W., Elkins J. M., Oldham N. J., Bhattacharya S., Gleadle J. M., et al. Hypoxia- inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 2002;277:26351–26355. doi: 10.1074/jbc.C200273200. [DOI] [PubMed] [Google Scholar]
- 16.Mahon P. C., Hirota K., Semenza G. L. FIH-1: a novel protein that interacts with HIF-1a and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001;15:2675–2686. doi: 10.1101/gad.924501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Dann C. E., III, Bruick R. K. Dioxygenases as O2-dependent regulators of the hypoxic response pathway. Biochem. Biophys. Res. Commun. 2005;338:639–647. doi: 10.1016/j.bbrc.2005.08.140. [DOI] [PubMed] [Google Scholar]
- 18.Hewitson K. S., Granatino N., Welford R. W. D., McDonough M. A., Schofield C. J. Oxidation by 2-oxoglutarate oxygenases: non-haem iron systems in catalysis and signalling. Philos. Trans. R. Soc. London A. 2004;363:807–828. doi: 10.1098/rsta.2004.1540. [DOI] [PubMed] [Google Scholar]
- 19.McNeill L. A., Hewitson K. S., Gleadle J., Horsfall L. E., Oldham N. J., Maxwell P., Pugh C. W., Ratcliffe P. J., Schofield C. J. The use of dioxygen by HIF prolyl hydroxylase (PHD1) Bioorg. Med. Chem. Lett. 2002;12:1547–1550. doi: 10.1016/s0960-894x(02)00219-6. [DOI] [PubMed] [Google Scholar]
- 20.Welford R. W., Kirkpatrick J. M., McNeill L. A., Puri M., Oldham N. J., Schofield C. J. Incorporation of oxygen into the succinate co-product of iron(II) and 2-oxoglutarate dependent oxygenases from bacteria, plants and humans. FEBS Lett. 2005;579:5170–5174. doi: 10.1016/j.febslet.2005.08.033. [DOI] [PubMed] [Google Scholar]
- 21.Hirsilä M., Koivunen P., Günzler V., Kivirikko K. I., Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 2003;278:30772–30780. doi: 10.1074/jbc.M304982200. [DOI] [PubMed] [Google Scholar]
- 22.Koivunen P., Hirsilä M., Günzler V., Kivirikko K. I., Myllyharju J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J. Biol. Chem. 2004;279:9899–9904. doi: 10.1074/jbc.M312254200. [DOI] [PubMed] [Google Scholar]
- 23.Pugh C. W., O' Rourke J. F., Nagao M., Gleadle J. M., Ratcliffe P. J. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. J. Biol. Chem. 1997;272:11205–11214. doi: 10.1074/jbc.272.17.11205. [DOI] [PubMed] [Google Scholar]
- 24.McNeill L. A., Bethge L., Hewitson K. S., Schofield C. J. A fluorescence- based assay for 2-oxoglutarate-dependent oxygenases. Anal. Biochem. 2005;336:125–131. doi: 10.1016/j.ab.2004.09.019. [DOI] [PubMed] [Google Scholar]
- 25.Searls T., Butler D., Chien W., Mukherji M., Lloyd M. D., Schofield C. J. Studies on the specificity of unprocessed and mature forms of phytanoyl-CoA 2-hydroxylase and mutation of the iron binding ligands. J. Lipid Res. 2005;46:1660–1667. doi: 10.1194/jlr.M500034-JLR200. [DOI] [PubMed] [Google Scholar]
- 26.van der Ploeg J. R., Weiss M. A., Saller E., Nashimoto H., Saito N., Kertesz M. A., Leisinger T. Identification of sulfate starvation-regulated genes in Escherichia coli: a gene cluster involved in the utilization of taurine as a sulfur source. J. Bacteriol. 1996;178:5438–5446. doi: 10.1128/jb.178.18.5438-5446.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Battino R., Rettich T. R., Tominaga T. The solubility of oxygen and ozone in liquids. J. Phys. Chem. Ref. Data. 1983;12:163–178. [Google Scholar]
- 28.Shaw A. D., Li Z., Thomas Z., Stevens C. W. Assessment of tissue oxygen tension: comparison of dynamic fluorescence quenching and polarographic electrode technique. Crit. Care. 2002;6:76–80. doi: 10.1186/cc1457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Leskovac V., Trivic S., Wohlfahrt G., Kandrac J., Pericin D. Glucose oxidase from Aspergillus niger: the mechanism of action with molecular oxygen, quinones, and one-electron acceptors. Int. J. Biochem. Cell Biol. 2005;37:731–750. doi: 10.1016/j.biocel.2004.10.014. [DOI] [PubMed] [Google Scholar]
- 30.Nakamura S., Hayashi S., Koga K. Effect of periodate oxidation on the structure and properties of glucose oxidase. Biochim. Biophys. Acta. 1976;445:294–308. doi: 10.1016/0005-2744(76)90084-x. [DOI] [PubMed] [Google Scholar]
- 31.Kivirikko K. I., Myllyla R., Pihlajaniemi T. Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit. FASEB J. 1989;3:1609–1617. [PubMed] [Google Scholar]
- 32.Knowles H. J., Raval R. R., Harris A. L., Ratcliffe P. J. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 2003;63:1764–1768. [PubMed] [Google Scholar]
- 33.Xu J., Jordan R. B. Kinetics and mechanism of the reaction of aqueous iron(III) with ascorbic acid. Inorg. Chem. 1990;29:4180–4184. [Google Scholar]
- 34.McNeill L. A., Flashman E., Buck M. R. G., Hewitson K. S., Clifton I. J., Jeschke G., Claridge T. D., Ehrismann D., Oldham N. J., Schofield C. J. Hypoxia- inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate. Mol. BioSyst. 2005;1:321–324. doi: 10.1039/b511249b. [DOI] [PubMed] [Google Scholar]
- 35.McDonough M. A., Li V., Flashman E., Chowdhury R., Mohr C., Lienard B. M., Zondlo J., Oldham N. J., Clifton I. J., Lewis J., et al. Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2) Proc. Natl. Acad. Sci. U.S.A. 2006;103:9814–9819. doi: 10.1073/pnas.0601283103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Mukherji M., Chien W., Kershaw N. J., Clifton I. J., Schofield C. J., Wierzbicki A. S., Lloyd M. D. Structure–function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease. Hum. Mol. Genet. 2001;10:1971–1982. doi: 10.1093/hmg/10.18.1971. [DOI] [PubMed] [Google Scholar]
- 37.Eichhorn E., van der Ploeg J. R., Kertesz M. A., Leisinger T. Characterization of a-ketoglutarate-dependent taurine dioxygenase from Escherichia coli. J. Biol. Chem. 1997;272:23031–23036. doi: 10.1074/jbc.272.37.23031. [DOI] [PubMed] [Google Scholar]
- 38.Baek J. H., Mahon P. C., Oh J., Kelly B., Krishnamachary B., Pearson M., Chan D. A., Giaccia A. J., Semenza G. L. OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha. Mol. Cell. 2005;17:503–512. doi: 10.1016/j.molcel.2005.01.011. [DOI] [PubMed] [Google Scholar]
- 39.Tuckerman J. R., Zhao Y., Hewitson K. S., Tian Y.-M., Pugh C. W., Ratcliffe P. J., Mole D. R. Determination and comparison of specific activity of the HIF-prolyl hydroxylase. FEBS Lett. 2004;576:145–150. doi: 10.1016/j.febslet.2004.09.005. [DOI] [PubMed] [Google Scholar]
- 40.Chan D. A., Sutphin P. D., Yen S. E., Giaccia A. J. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Mol. Cell. Biol. 2005;25:6415–6426. doi: 10.1128/MCB.25.15.6415-6426.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Schofield C. J., Ratcliffe P. J. Signalling hypoxia by HIF hydroxylases. Biochem. Biophys. Res. Commun. 2005;338:617–626. doi: 10.1016/j.bbrc.2005.08.111. [DOI] [PubMed] [Google Scholar]
- 42.Metzen E., Wolff M., Fandrey J., Jelkmann W. Pericellular PO2 and O2 consumption in monolayer cell cultures. Respir. Physiol. 1995;100:101–106. doi: 10.1016/0034-5687(94)00125-j. [DOI] [PubMed] [Google Scholar]
- 43.Gerald D., Berra E., Frapart Y. M., Chan D. A., Giaccia A. J., Mansuy D., Pouyssegur J., Yaniv M., Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell. 2004;118:781–794. doi: 10.1016/j.cell.2004.08.025. [DOI] [PubMed] [Google Scholar]
- 44.Guzy R. D., Schumacker P. T. Oxygen sensing by mitochondria at complex III: the paradox of increased ROS during hypoxia. Exp. Physiol. 2006;91:807–819. doi: 10.1113/expphysiol.2006.033506. [DOI] [PubMed] [Google Scholar]





